Recent advances in the prevention and treatment of skin cancer using photodynamic therapy

Abstract

Photodynamic therapy (PDT) is a noninvasive procedure that involves a photosensitizing drug and its subsequent activation by light to produce reactive oxygen species that specifically destroy target cells. Recently, PDT has been widely used in treating non-melanoma skin malignancies, the most common cancer in the USA, with superior cosmetic outcomes compared with conventional therapies. The topical 'photosensitizers' commonly used are 5-aminolevulinic acid (ALA) and its esterified derivative methyl 5-aminolevulinate, which are precursors of the endogenous photosensitizer protoporphyrin IX. After treatment with ALA or methyl 5-aminolevulinate, protoporphyrin IX preferentially accumulates in the lesion area of various skin diseases, which allows not only PDT treatment but also fluorescence diagnosis with ALA-induced porphyrins. Susceptible lesions include various forms of non-melanoma skin cancer such as actinic keratosis, basal cell carcinoma and squamous cell carcinoma. The most recent and promising developments in PDT include the discovery of new photosensitizers, the exploitation of new drug delivery systems and the combination of other modalities, which will all contribute to increasing PDT therapeutic efficacy and improving outcome. This article summarizes the main principles of PDT and its current clinical use in the management of non-melanoma skin cancers, as well as recent developments and possible future research directions.Keywords 5-aminolevulinic acid; ALA; MAL; methyl 5-aminolevulinate; PDT; photodynamic therapy; photosensitizers; skin cancer; topical PDT Skin cancer is the most common form of cancer, accounting for nearly half of all cancers in the USA [1]. The most common types of skin cancer are non-melanoma skin cancers (NMSCs): basal cell carcinoma (BCC), which forms in the basal cells, and squamous cell carcinoma (SCC), which forms in the squamous cells. BCCs are rarely fatal, but can be † Author for correspondence: Tel.: +1 773 795 4696, Fax: +1 773 702 8398, yyhe@medicine.bsd.uchicago.edu. Financial & competing interests disclosureWork in the authors' laboratories was supported by the American Skin Association, the University of Chicago Cancer Research Center (P30 CA014599), and the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript. NIH Public Access Author ManuscriptExpert Rev Anticancer Ther. Author manuscript; available in PMC 2011 September 1. Genetic factors and environmental exposure to UV radiation in sunlight or tanning beds are strong risk factors for the genesis of skin cancer. Traditional skin c...

Aminophthalocyanine-Mediated Photodynamic Inactivation of Leishmania tropica

“…PS can be applied exogenously, as is the case with phthalocyanines. Alternatively, PS can be induced endogenously with delta-aminolevulinate (ALA) to upregulate heme biosynthesis of the target cells for overproducing photosensitive intermediates of this pathway, i.e., porphyrins (2). PDT has the potential to solve the significant problems of emerging drug resistance in infectious and malignant diseases, since it is not known to elicit such resistance (3,4).…”

Delta-Aminolevulinate-Induced Host-Parasite Porphyric Disparity for Selective Photolysis of Transgenic Leishmania in the Phagolysosomes of Mononuclear Phagocytes: a Potential Novel Platform for Vaccine Delivery

“…Since all porphyrins when exposed to light generate cytolytic reactive oxygen species (ROS), ALA has been used clinically to produce endogenous porphyrins for photolytic elimination of unwanted or pathological cells or tissues, e.g., photodynamic therapy for skin tumors (21,40). Although ALA-induced elevation of porphyrins is often low and transient in mammalian cells, there are several advantages to this approach instead of direct administration of porphyrins or other photosensitizers.…”

Photodynamic therapy in the treatment of onychomycosis – a review

“…The basic rule of photobiology states that the longer the wavelength, the deeper the penetration into the tissue. Since the human skin is easily accessible to light, PDT offers greater opportunities and enables the use of a wider wavelength range [10,11].…”

“…Podstawowa zasada fotobiologii jest taka, że im długość fali jest większa, tym przenikanie w głąb tkanki większe. Ponieważ ludzka skóra jest łatwo dostępna dla światła, zastosowanie PDT daje większe możliwości i można stosować szerszy zakres długości fali [10,11]. acids and amino acids.…”